Ratings by Stephens (Mason Carrico)

More Stocks Rated by Stephens
Date CompanySymbol Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
5/13/2026 Cytek Biosciences Inc CTKB Maintain Overweight
(N/A)		  
 		   Details
11/13/2025 Natera NTRA Maintain Overweight
(N/A)		  
 		   Details
11/10/2025 Pacific Biosciences of California PACB Maintain Overweight
(N/A)		  
 		   Details
10/22/2025 Hologic HOLX Downgrade Equal Weight
(Overweight)		 73.98
(76.01)		 2.74% Details
9/2/2025 Neogenomics NEO Maintain Overweight
(N/A)		  
 		   Details
8/4/2025 Illumina ILMN Maintain Overweight
(N/A)		  
 		   Details
7/9/2025 Procept BioRobotics Corp PRCT New Coverage Overweight
(N/A)		 57.91
(19.22)		 -66.81% Details
5/16/2025 Cytek Biosciences Inc CTKB Maintain Overweight
(N/A)		  
 		   Details
5/12/2025 Hologic HOLX Maintain Overweight
(N/A)		  
 		   Details
3/25/2025 Akoya Biosciences Inc AKYA Downgrade Equal Weight
(Overweight)		 1.67
(1.29)		 -22.75% Details
1/29/2025 Paragon 28, Inc FNA Downgrade Equal Weight
(Overweight)		 12.00
(13.09)		 9.08% Details
12/11/2024 Hologic HOLX Maintain Overweight
(Overweight)		  
 		   Details
11/12/2024 Illumina ILMN Maintain Overweight
(N/A)		  
 		   Details
10/11/2024 Myriad Genetics MYGN Maintain Equal Weight
(N/A)		  
 		   Details
8/13/2024 Pacific Biosciences of California PACB Maintain Overweight
(N/A)		  
 		   Details
6/27/2024 Hologic HOLX New Coverage Overweight
(N/A)		 71.65
(73.98)		 3.25% Details
5/13/2024 CareDx, Inc CDNA Maintain Overweight
(N/A)		  
 		   Details
4/17/2024 CareDx, Inc CDNA Maintain Overweight
(N/A)		  
 		   Details
3/5/2024 DermTech Inc. DMTK Maintain Equal Weight
(Equal Weight)		  
 		   Details
12/14/2023 Cytek Biosciences Inc CTKB New Coverage Overweight
(N/A)		 7.55
(4.62)		 -38.81% Details
12/14/2023 Pacific Biosciences of California PACB New Coverage Overweight
(N/A)		 8.31
(1.44)		 -82.67% Details
12/14/2023 Illumina ILMN New Coverage Overweight
(N/A)		 117.64
(186.65)		 58.66% Details
11/13/2023 Akoya Biosciences Inc AKYA Maintain Overweight
(N/A)		  
 		   Details
11/9/2023 CareDx, Inc CDNA Upgrade Overweight
(Equal Weight)		 6.33
(39.73)		 527.65% Details
8/21/2023 Neogenomics NEO Upgrade Overweight
(Equal Weight)		 13.55
(14.61)		 7.82% Details
5/8/2023 DermTech Inc. DMTK Downgrade Equal Weight
(Overweight)		 2.31
(0.09)		 -96.1% Details
3/31/2023 10X Genomics TXG New Coverage Overweight
(N/A)		 50.74
(43.74)		 -13.8% Details
3/7/2023 CareDx, Inc CDNA Downgrade Equal Weight
(Overweight)		 10.65
(39.73)		 273.05% Details
3/6/2023 Myriad Genetics MYGN Maintain Equal Weight
(N/A)		  
 		   Details
2/28/2023 fuboTV FUBO Maintain Equal Weight
(N/A)		  
 		   Details
11/8/2022 DermTech Inc. DMTK Maintain Overweight
(N/A)		  
 		   Details
11/7/2022 Guardant Health GH Maintain Overweight
(N/A)		  
 		   Details
10/6/2022 Guardant Health GH New Coverage Overweight
(N/A)		 59.62
(155.87)		 161.44% Details
10/6/2022 Myriad Genetics MYGN New Coverage Equal Weight
(N/A)		 20.61
(6.18)		 -70.01% Details
10/6/2022 Akoya Biosciences Inc AKYA New Coverage Overweight
(N/A)		 12.69
(1.29)		 -89.83% Details
8/12/2022 DermTech Inc. DMTK Maintain Overweight
(N/A)		  
 		   Details
5/24/2022 OncoCyte Corp OCX Downgrade Equal Weight
(Overweight)		 1.08
(3.20)		 196.3% Details
4/25/2022 fuboTV FUBO New Coverage Equal Weight
(N/A)		 4.55
(9.72)		 113.63% Details
4/25/2022 CareDx, Inc CDNA New Coverage Overweight
(N/A)		 30.57
(39.73)		 29.96% Details
4/25/2022 Natera NTRA New Coverage Overweight
(N/A)		 36.29
(271.39)		 647.84% Details
3/29/2022 Neogenomics NEO Downgrade Equal Weight
(Overweight)		 17.79
(14.61)		 -17.88% Details
3/2/2022 Veracyte, Inc VCYT Maintain Overweight
(N/A)		  
 		   Details
1/18/2022 Neogenomics NEO New Coverage Overweight
(N/A)		 24.94
(14.61)		 -41.42% Details
1/7/2022 OncoCyte Corp OCX New Coverage Overweight
(N/A)		 2.06
(3.20)		 55.34% Details